For the quarter ending 2026-03-31, IMUX has $189,742K in assets. $38,509K in debts. $186,629K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 186,629 | 15,483 | 35,132 | 55,310 |
| Prepaid expenses and other current assets | 2,130 | 7,386 | 4,141 | 4,532 |
| Total current assets | 188,759 | 22,869 | 39,273 | 59,842 |
| Property and equipment, net | 566 | 608 | 640 | 612 |
| Right-of-use assets, net | 417 | 575 | 791 | 975 |
| Total assets | 189,742 | 24,052 | 40,704 | 61,429 |
| Accounts payable | 11,011 | 10,138 | 7,918 | 7,893 |
| Accrued expenses | 22,432 | 18,645 | 19,454 | 18,113 |
| Other current liabilities | 4,920 | 1,835 | 2,707 | 1,307 |
| Total current liabilities | 38,363 | 30,618 | 30,079 | 27,313 |
| Operating lease liabilities | 146 | 107 | 126 | 205 |
| Total long-term liabilities | 146 | 107 | 126 | 205 |
| Total liabilities | 38,509 | 30,725 | 30,205 | 27,518 |
| Common stock, 0.0001 par value 500,000,000 shares authorized as of march 31, 2026 and december 31, 2025 and 13,621,483 and 12,038,263 shares issued and outstanding as of march 31, 2026 and december31, 2025, respectively | 11 | 9 | 9 | 9 |
| Additional paid-in capital | 789,324 | 599,241 | 597,179 | 595,069 |
| Accumulated other comprehensive income | 3,057 | 2,648 | 2,582 | 2,525 |
| Accumulated deficit | -641,159 | -608,571 | -589,271 | -563,692 |
| Total stockholders equity (deficit) | 151,233 | -6,673 | 10,499 | 33,911 |
| Total liabilities and stockholders equity (deficit) | 189,742 | 24,052 | 40,704 | 61,429 |
IMMUNIC, INC. (IMUX)
IMMUNIC, INC. (IMUX)